Products and Services

Device developer Merxin has announced that a European generics company has acquired exclusive worldwide rights for development of a tiotropium/olodaterol product for the treatment of COPD using Merxin’s MRX004 softmist inhaler. Boehringer Ingelheim markets its… Read more . . .

Catalent will continue to offer DPI development and manufacturing services at the Nottingham, UK Juniper Pharma Services facility that was part of its recently completed acquisition of Juniper Pharmaceuticals, the company says. Catalent announced its… Read more . . .

According to DFE Pharma, the company has significantly increased production capacities of its excipients, including all of its inhalation grade lactose products. The company said that it achieved the improved supply through investments at facilities… Read more . . .

Copley Scientific has announced the launch of an upgraded NGI Assistant for automated drug recovery from NGI cascade impactors for inhaler testing. According to Copley, the new model features a simplified interface and shorter cycle… Read more . . .

Nanopharm Limited has announced an agreement with US-based Sciarra Laboratories that will pair Nanopharm’s SmartTrack OINDP development services with Sciarra’s GMP metered dose inhaler manufacturing services. Together, Nanopharm and Sciarra will comprise a CDMO with… Read more . . .

In a business update, Gerresheimer announced that it has gained one large order for inhaler manufacturing in Europe but has lost another because “the customer’s inhaler business fell short of its expectations.” As a result,… Read more . . .

Inhalation Sciences subsidiary Ziccum has been awarded a grant of 500,000 SEK (~ €48,600) by the EU’s Horizon 2020 research and innovation project for scale up of its LaminarPace spray drying technology, the company said.… Read more . . .

Amiko Digital Health has announced that Portuguese health care group Luz Saúde has signed an agreement for the use of Amiko’s Respiro inhaler monitoring platform for asthma and COPD management. Earlier this year, Amiko announced… Read more . . .

Catalent has announced that it will acquire Juniper Pharma Services (formerly Molecular Profiles) along with its parent company Juniper Pharmaceuticals. Catalent will pay $11.50 per share to acquire all of Juniper Pharmaceuticals’ stock. Juniper Pharmaceuticals… Read more . . .